Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free RSSS Stock Alerts

Research Solutions (RSSS) Financials

Research Solutions logo
$2.20 -0.01 (-0.45%)
Closing price 07/20/2026 04:00 PM Eastern
Extended Trading
$2.22 +0.01 (+0.68%)
As of 07/20/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Research Solutions

Annual Income Statements for Research Solutions

This table shows Research Solutions' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 0.77 -0.50 -2.29 -1.68 -0.96 -19 -0.29 -1.63 0.57 -3.79 1.27
Consolidated Net Income / (Loss)		 0.77 -0.50 -2.29 -1.68 -0.96 -0.66 -0.29 -1.63 0.57 -3.79 1.27
Net Income / (Loss) Continuing Operations		 -0.54 -1.36 -3.11 -1.94 -1.17 -0.78 -0.29 -1.63 0.57 -3.79 1.27
Total Pre-Tax Income 		-0.51 -1.34 -3.07 -1.90 -1.15 -0.77 -0.28 -1.62 0.58 -3.67 1.35
Total Operating Income		 -0.49 -1.29 -3.08 -1.95 -1.25 -0.85 -0.28 -1.63 0.24 -0.77 2.50
Total Gross Profit		 6.18 5.63 6.10 7.35 8.34 9.64 10 12 15 20 24
Total Revenue		 32 24 26 28 29 27 32 33 38 45 49
Operating Revenue		 32 24 26 28 29 27 32 33 38 45 49
Total Cost of Revenue		 26 18 20 21 20 43 21 21 23 25 25
Operating Cost of Revenue		 26 18 20 21 20 43 21 21 23 25 25
Total Operating Expenses		 6.67 6.92 9.19 9.30 9.60 10 11 14 14 20 22
Selling, General & Admin Expense		 6.50 6.83 9.06 9.15 9.56 10 11 14 14 20 20
Depreciation Expense		 0.17 0.09 0.13 0.15 0.04 0.02 0.01 0.02 0.05 0.84 1.25
Total Other Income / (Expense), net		 -0.02 -0.05 0.01 0.05 0.11 0.08 0.00 0.01 0.34 -2.90 -1.15
Other Income / (Expense), net		 0.00 -0.03 0.02 0.06 0.11 0.08 0.00 0.01 0.34 -2.90 -1.15
Income Tax Expense		 0.03 0.03 0.04 0.04 0.03 0.01 0.00 0.01 0.01 0.11 0.08
Basic Earnings per Share		 $0.04 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) - ($0.06) $0.02 ($0.13) $0.04
Weighted Average Basic Shares Outstanding		 17.45M 17.77M 23.24M 23.47M 23.82M 24.76M 26.01M 26.42M 26.86M 28.86M 30.68M
Diluted Earnings per Share		 $0.04 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) - ($0.06) $0.02 ($0.13) $0.04
Weighted Average Diluted Shares Outstanding		 17.96M 17.77M 23.24M 23.47M 23.82M 24.76M 26.01M 26.42M 29.14M 28.86M 31.50M
Weighted Average Basic & Diluted Shares Outstanding		 18.39M 17.77M 23.24M 23.47M 23.82M 24.76M 26.01M 27.33M 29.60M 32.55M 32.83M

Quarterly Income Statements for Research Solutions

This table shows Research Solutions' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -0.99 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86
Consolidated Net Income / (Loss)		 -0.99 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86
Net Income / (Loss) Continuing Operations		 -0.99 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86
Total Pre-Tax Income 		-0.96 -0.04 0.12 -2.79 0.72 -1.97 0.23 2.37 0.77 0.56 0.88
Total Operating Income		 -1.10 -0.42 0.09 0.66 0.65 0.09 0.56 1.20 0.96 0.74 1.04
Total Gross Profit		 4.03 4.48 5.48 5.64 5.77 5.82 6.27 6.34 6.23 6.18 6.27
Total Revenue		 10 10 12 12 12 12 13 12 12 12 12
Operating Revenue		 10 10 12 12 12 12 13 12 12 12 12
Total Cost of Revenue		 6.03 5.83 6.63 6.49 6.28 6.09 6.39 6.10 6.09 5.62 5.86
Operating Cost of Revenue		 6.03 5.83 6.63 6.49 6.28 6.09 6.39 6.10 6.09 5.62 5.86
Total Operating Expenses		 5.13 4.90 5.39 4.98 5.12 5.73 5.71 5.14 5.26 5.44 5.22
Selling, General & Admin Expense		 5.07 4.75 5.08 4.67 4.81 5.42 5.40 4.82 4.95 5.12 4.91
Depreciation Expense		 0.06 0.16 0.31 0.31 0.31 0.31 0.31 0.32 0.32 0.32 0.31
Total Other Income / (Expense), net		 0.14 0.38 0.03 -3.45 0.07 -2.06 -0.33 1.16 -0.19 -0.18 -0.16
Interest Expense		 - - - - - - 0.00 - - - 0.25
Other Income / (Expense), net		 0.14 0.38 0.03 -3.45 0.07 -2.06 -0.33 1.16 -0.19 -0.18 0.08
Income Tax Expense		 0.03 0.01 0.04 0.03 0.05 0.02 0.01 0.01 0.02 0.01 0.02
Basic Earnings per Share		 ($0.04) $0.00 $0.00 ($0.09) $0.02 ($0.07) $0.01 $0.08 $0.02 $0.02 $0.03
Weighted Average Basic Shares Outstanding		 27.05M 28.09M 30.02M 28.86M 30.35M 30.42M 31.03M 30.68M 31.23M 31.63M 32.00M
Diluted Earnings per Share		 ($0.04) $0.00 $0.00 ($0.09) $0.02 ($0.07) $0.01 $0.08 $0.02 $0.02 $0.03
Weighted Average Diluted Shares Outstanding		 27.05M 28.09M 33.51M 28.86M 31.20M 30.42M 32.14M 31.50M 32.07M 32.33M 32.44M
Weighted Average Basic & Diluted Shares Outstanding		 29.62M 32.62M 32.28M 32.55M 32.51M 32.65M 32.46M 32.83M 32.87M 32.91M 33.45M

Annual Cash Flow Statements for Research Solutions

This table details how cash moves in and out of Research Solutions' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents		 -0.53 4.72 -0.30 -0.87 0.66 3.96 1.69 -0.40 2.94 -7.45 6.13
Net Cash From Operating Activities		 -0.33 0.19 -0.44 -0.61 0.58 2.42 1.87 -0.42 3.38 3.55 7.02
Net Cash From Continuing Operating Activities		 -0.30 0.19 -0.44 -0.61 0.79 2.42 1.87 -0.42 3.38 3.55 7.02
Net Income / (Loss) Continuing Operations		 0.77 -0.50 -2.29 -1.68 -1.17 -0.66 -0.29 -1.63 0.57 -3.79 1.27
Consolidated Net Income / (Loss)		 0.77 -0.50 -2.29 -1.68 -0.96 -0.66 -0.29 -1.63 0.57 -3.79 1.27
Depreciation Expense		 0.17 0.09 0.13 0.15 0.04 0.02 0.01 0.02 0.05 0.84 1.25
Non-Cash Adjustments To Reconcile Net Income		 -0.48 0.71 0.39 1.01 0.83 0.83 1.01 1.03 1.92 2.16 1.72
Changes in Operating Assets and Liabilities, net		 -0.76 -0.12 1.29 -0.20 0.77 2.10 1.06 0.17 0.84 4.35 2.79
Net Cash From Investing Activities		 -0.10 -0.20 0.36 -0.09 -0.02 0.00 -0.02 -0.04 -0.34 -10 -0.02
Net Cash From Continuing Investing Activities		 -0.10 -0.20 0.36 -0.09 -0.02 0.00 -0.02 -0.04 -0.34 -10 -0.02
Purchase of Property, Plant & Equipment		 -0.07 -0.06 -0.06 -0.03 -0.02 0.00 -0.02 -0.04 -0.34 -0.07 -0.02
Acquisitions		 -0.03 -0.14 -0.01 -0.06 - - - - 0.00 -10 0.00
Net Cash From Financing Activities		 -0.12 4.75 -0.20 -0.15 -0.10 1.55 -0.16 0.06 -0.10 -0.91 -0.88
Net Cash From Continuing Financing Activities		 -0.05 4.75 -0.20 -0.15 -0.10 1.55 -0.16 0.06 -0.10 -0.91 -0.88
Repurchase of Common Equity		 -0.05 -0.04 -0.20 -0.15 -0.20 -0.32 -0.18 -0.09 -0.10 -0.55 -0.93
Other Financing Activities, net		 - - - - 0.10 1.88 0.33 0.16 0.01 -0.35 0.06
Other Net Changes in Cash		 - - - - - - 0.00 - 0.00 0.00 0.00
Cash Income Taxes Paid		 0.03 0.03 0.04 0.04 0.03 0.01 0.00 0.01 0.01 0.11 0.08

Quarterly Cash Flow Statements for Research Solutions

This table details how cash moves in and out of Research Solutions' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -3.66 -7.18 1.52 1.88 0.82 0.78 2.15 2.38 -0.27 0.31 -0.21
Net Cash From Operating Activities		 -0.76 0.33 2.02 1.96 0.84 1.03 2.89 2.26 1.11 1.38 1.01
Net Cash From Continuing Operating Activities		 -0.76 0.33 2.02 1.96 0.84 1.03 2.89 2.26 1.11 1.38 1.01
Net Income / (Loss) Continuing Operations		 -0.99 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86
Consolidated Net Income / (Loss)		 -0.99 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86
Depreciation Expense		 0.06 0.16 0.31 0.31 0.31 0.31 0.31 0.32 0.32 0.32 0.31
Non-Cash Adjustments To Reconcile Net Income		 0.59 0.60 0.54 0.43 0.42 0.53 0.59 0.18 0.21 0.21 1.09
Changes in Operating Assets and Liabilities, net		 -0.42 -0.37 1.09 4.05 -0.56 2.17 1.77 -0.59 -0.17 0.31 -1.26
Net Cash From Investing Activities		 -2.75 -7.33 -0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00
Net Cash From Continuing Investing Activities		 -2.75 -7.33 -0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00
Purchase of Property, Plant & Equipment		 -0.03 -0.02 -0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00
Net Cash From Financing Activities		 -0.16 -0.19 -0.49 -0.07 -0.02 -0.25 -0.73 0.12 -1.36 -1.08 -1.22
Net Cash From Continuing Financing Activities		 -0.16 -0.19 -0.49 -0.07 -0.02 -0.25 -0.73 0.12 -1.36 -1.08 -1.22
Repurchase of Common Equity		 -0.05 -0.02 -0.45 -0.03 -0.02 -0.19 -0.70 -0.03 -0.02 -0.02 -0.01
Other Financing Activities, net		 -0.11 -0.17 -0.04 -0.04 0.00 -0.06 -0.03 0.15 -1.34 -1.06 -1.21
Cash Income Taxes Paid		 0.03 0.01 0.04 0.03 0.05 0.02 0.01 0.01 0.02 0.01 0.02

Annual Balance Sheets for Research Solutions

This table presents Research Solutions' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets		 7.05 12 13 9.96 10 15 17 17 22 42 46
Total Current Assets		 6.96 12 12 9.58 10 15 17 17 21 15 20
Cash & Equivalents		 1.35 6.08 5.77 4.91 5.35 9.31 11 11 14 6.10 12
Accounts Receivable		 5.16 5.76 5.47 4.25 4.49 4.45 4.72 5.25 6.15 6.88 7.19
Prepaid Expenses		 0.44 0.34 0.76 0.42 0.32 0.96 1.18 1.12 1.60 1.71 0.58
Plant, Property, & Equipment, net		 0.08 0.08 0.09 0.06 0.04 0.01 0.02 0.05 0.07 0.09 0.06
Total Noncurrent Assets		 0.01 0.11 0.47 0.32 0.21 0.08 0.00 0.00 0.46 27 26
Goodwill		 - - - - - - - - 0.00 16 16
Intangible Assets		 0.00 0.10 0.04 - - - - 0.00 0.46 11 9.69
Other Noncurrent Operating Assets		 0.01 0.01 0.43 0.32 0.21 0.08 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 7.05 12 13 9.96 10 15 17 17 22 42 46
Total Liabilities		 5.96 6.33 8.22 6.68 7.38 9.95 11 12 15 30 32
Total Current Liabilities		 5.96 6.33 7.89 6.47 7.30 9.95 11 12 15 18 26
Short-Term Debt		 - - - - - - - - - 0.00 7.36
Accounts Payable		 5.61 5.69 6.44 4.69 4.86 6.35 6.69 6.60 8.08 8.84 7.44
Current Deferred Revenue		 0.35 0.64 1.34 1.67 2.31 3.52 4.80 5.54 6.42 9.02 11
Total Noncurrent Liabilities		 0.00 0.00 0.33 0.21 0.08 0.00 0.00 0.00 0.00 12 6.68
Noncurrent Deferred Revenue		 - - - - - - - - - - 0.00
Other Noncurrent Operating Liabilities		 - 0.00 0.33 0.21 0.08 - - - 0.00 12 6.68
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1.09 6.04 4.34 3.28 3.03 4.86 5.43 4.88 7.33 12 14
Total Preferred & Common Equity		 1.09 6.04 4.34 3.28 3.03 4.86 5.43 4.88 7.33 12 14
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1.09 6.04 4.34 3.28 3.03 4.86 5.43 4.88 7.33 12 14
Common Stock		 16 22 22 23 24 26 27 28 30 38 39
Retained Earnings		 -15 -16 -18 -20 -21 -21 -21 -23 -23 -26 -25
Accumulated Other Comprehensive Income / (Loss)		 -0.03 -0.04 -0.07 -0.09 -0.11 -0.13 -0.12 -0.12 -0.12 -0.12 -0.12

Quarterly Balance Sheets for Research Solutions

This table presents Research Solutions' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 24 39 41 41 43 45 46 44 46
Total Current Assets		 18 12 13 14 16 19 20 19 21
Cash & Equivalents		 9.88 2.70 4.22 6.92 7.70 9.85 12 12 12
Accounts Receivable		 6.46 7.29 7.32 6.30 7.12 7.60 6.90 5.66 7.60
Prepaid Expenses		 1.48 1.63 1.64 1.22 1.33 1.38 0.80 0.75 1.03
Plant, Property, & Equipment, net		 0.09 0.10 0.09 0.07 0.06 0.06 0.07 0.07 0.06
Total Noncurrent Assets		 5.77 28 28 27 27 26 26 26 25
Goodwill		 3.24 16 16 16 16 16 16 16 16
Intangible Assets		 2.53 11 11 10 10 9.96 9.41 9.13 8.84
Other Noncurrent Operating Assets		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 24 39 41 41 43 45 46 44 46
Total Liabilities		 17 25 27 29 32 34 30 27 27
Total Current Liabilities		 15 17 18 16 21 25 25 24 25
Short-Term Debt		 - - - - 3.96 6.02 7.30 7.30 7.31
Accounts Payable		 8.54 8.86 9.01 8.26 8.10 8.53 7.60 6.40 6.69
Current Deferred Revenue		 6.39 7.84 8.87 8.05 8.85 10 9.98 9.92 11
Total Noncurrent Liabilities		 1.87 8.79 8.79 12 11 9.09 5.04 3.41 1.78
Noncurrent Deferred Revenue		 - - - - - - - - 0.06
Other Noncurrent Operating Liabilities		 1.87 8.79 8.79 12 11 9.09 5.04 3.41 1.73
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 6.89 14 14 13 11 11 16 17 19
Total Preferred & Common Equity		 6.89 14 14 13 11 11 16 17 19
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 6.89 14 14 13 11 11 16 17 19
Common Stock		 31 38 38 39 39 39 40 41 42
Retained Earnings		 -24 -24 -23 -26 -28 -27 -24 -24 -23
Accumulated Other Comprehensive Income / (Loss)		 -0.12 -0.11 -0.11 -0.12 -0.12 -0.13 -0.12 -0.11 -0.11

Annual Metrics And Ratios for Research Solutions

This table displays calculated financial ratios and metrics derived from Research Solutions' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
DEI Shares Outstanding		 18,075,265.00 18,582,860.00 23,925,910.00 23,980,383.00 24,334,102.00 26,034,572.00 26,352,008.00 27,064,215.00 29,500,764.00 32,282,039.00 32,458,727.00
DEI Adjusted Shares Outstanding		 18,075,265.00 18,582,860.00 23,925,910.00 23,980,383.00 24,334,102.00 26,034,572.00 26,352,008.00 27,064,215.00 29,500,764.00 32,282,039.00 32,458,727.00
DEI Earnings Per Adjusted Shares Outstanding		 0.04 -0.03 -0.10 -0.07 -0.04 -0.73 -0.01 -0.06 0.02 -0.12 0.04
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 12.00% -24.48% 6.87% 8.82% 2.77% -5.65% 16.89% 3.71% 14.48% 18.35% 9.94%
EBITDA Growth		 61.83% -285.50% -134.78% 43.48% 38.99% 36.78% 68.48% -711.54% 139.19% -550.45% 191.42%
EBIT Growth		 53.21% -167.28% -132.16% 38.19% 39.34% 32.75% 63.48% -476.39% 135.53% -736.41% 136.70%
NOPAT Growth		 53.13% -160.23% -139.72% 36.78% 35.65% 32.12% 66.78% -476.58% 120.68% -327.97% 535.81%
Net Income Growth		 141.48% -164.30% -360.69% 26.81% 42.82% 31.01% 56.95% -472.59% 135.02% -762.43% 133.42%
EPS Growth		 136.36% -175.00% -233.33% 30.00% 42.86% 25.00% 0.00% 0.00% 133.33% -750.00% 130.77%
Operating Cash Flow Growth		 -169.76% 155.79% -335.91% -38.57% 195.23% 319.55% -22.74% -122.33% 911.09% 4.94% 97.78%
Free Cash Flow Firm Growth		 -158.58% -9.35% 32.01% -52.23% 84.05% 925.73% -39.63% -207.94% 173.16% -1,787.58% 90.91%
Invested Capital Growth		 72.35% 86.29% -3,890.53% -13.95% -42.52% -91.81% -25.26% -2.55% -8.66% 190.01% 62.03%
Revenue Q/Q Growth		 -0.35% -28.40% 52.05% 1.18% 1.08% -11.35% 15.34% 1.06% 3.85% 5.12% 0.62%
EBITDA Q/Q Growth		 -404.19% -62.20% 6.42% 27.41% -4.82% 18.99% -152.71% -27.40% 415.21% -7,208.42% 200.97%
EBIT Q/Q Growth		 -316.37% -57.91% 5.07% 24.63% -2.00% 16.33% -45.51% -27.31% 344.78% -623.82% 135.39%
NOPAT Q/Q Growth		 -271.69% -57.51% 4.53% 23.57% -2.82% 17.33% -42.29% -27.76% 173.34% 34.56% 71.26%
Net Income Q/Q Growth		 72.26% 30.92% -17.98% 15.89% 1.37% 9.72% -44.88% -27.23% 335.83% -542.21% 132.32%
EPS Q/Q Growth		 0.00% 40.00% -11.11% 22.22% -33.33% 0.00% 0.00% 0.00% 300.00% -333.33% 130.77%
Operating Cash Flow Q/Q Growth		 -167.88% -69.33% 65.67% -21.93% -18.22% 85.26% -43.97% 44.69% 82.14% 14.50% 4.43%
Free Cash Flow Firm Q/Q Growth		 -75.81% -249.48% 72.48% -117.50% -553.25% 306.41% -62.18% 33.38% 1,742.30% 25.03% -128.93%
Invested Capital Q/Q Growth		 48.44% 95.26% -504.76% -9.57% 2.54% -27.91% 8.12% -4.70% -8.27% -43.53% 22.51%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 19.36% 23.39% 23.71% 26.23% 28.98% 35.48% 32.39% 36.50% 38.99% 44.01% 49.32%
EBITDA Margin		 -1.00% -5.10% -11.19% -5.81% -3.45% -2.31% -0.62% -4.88% 1.67% -6.36% 5.29%
Operating Margin		 -1.55% -5.34% -11.98% -6.96% -4.36% -3.14% -0.89% -4.96% 0.63% -1.72% 5.10%
EBIT Margin		 -1.55% -5.47% -11.89% -6.75% -3.99% -2.84% -0.89% -4.93% 1.53% -8.23% 2.75%
Profit (Net Income) Margin		 2.43% -2.07% -8.91% -5.99% -3.33% -2.44% -0.90% -4.96% 1.52% -8.49% 2.58%
Tax Burden Percent		 -151.42% 37.27% 74.64% 88.54% 83.65% 85.80% 101.14% 100.47% 99.03% 103.08% 93.86%
Interest Burden Percent		 103.66% 101.32% 100.39% 100.21% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.97% 0.00% 6.14%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 32.03%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 51.77%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -22.15%
Return on Equity (ROE)		 229.78% -13.96% -44.17% -44.04% -30.42% -16.79% -5.54% -31.66% 9.36% -39.81% 9.88%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -220.72% -15.31%
Operating Return on Assets (OROA)		 -6.13% -13.57% -24.55% -16.80% -11.27% -6.12% -1.78% -9.57% 2.97% -11.53% 3.07%
Return on Assets (ROA)		 9.62% -5.13% -18.40% -14.91% -9.42% -5.25% -1.80% -9.62% 2.94% -11.89% 2.88%
Return on Common Equity (ROCE)		 229.78% -13.96% -44.17% -44.04% -30.42% -16.79% -5.54% -31.66% 9.36% -39.81% 9.88%
Return on Equity Simple (ROE_SIMPLE)		 70.85% -8.24% -52.79% -51.19% -31.66% -13.63% -5.25% -33.43% 7.80% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.35 -0.90 -2.16 -1.37 -0.88 -0.60 -0.20 -1.14 0.24 -0.54 2.35
NOPAT Margin		 -1.09% -3.74% -8.39% -4.87% -3.05% -2.20% -0.62% -3.47% 0.63% -1.21% 4.79%
Net Nonoperating Expense Percent (NNEP)		 119.16% 10.84% -2.27% -5.87% -1.59% -0.90% -0.86% -4.54% 2.78% -33.07% -19.74%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - -4.61% 11.03%
Cost of Revenue to Revenue		 80.64% 76.61% 76.29% 73.77% 71.02% 157.69% 67.61% 63.50% 61.01% 55.99% 50.68%
SG&A Expenses to Revenue		 20.36% 28.35% 35.17% 32.65% 33.20% 38.52% 33.25% 41.40% 38.22% 43.86% 41.68%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 20.91% 28.73% 35.69% 33.19% 33.33% 38.61% 33.28% 41.45% 38.36% 45.74% 44.22%
Earnings before Interest and Taxes (EBIT)		 -0.49 -1.32 -3.06 -1.89 -1.15 -0.77 -0.28 -1.62 0.58 -3.67 1.35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.32 -1.23 -2.88 -1.63 -0.99 -0.63 -0.20 -1.61 0.63 -2.84 2.59
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 19.85 3.69 6.61 9.51 22.31 12.70 13.89 9.86 8.21 7.04 6.69
Price to Tangible Book Value (P/TBV)		 19.85 3.76 6.67 9.51 22.31 12.70 13.89 9.86 8.76 0.00 0.00
Price to Revenue (P/Rev)		 0.68 0.93 1.12 1.11 2.35 2.27 2.37 1.46 1.60 1.84 1.90
Price to Earnings (P/E)		 28.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 105.28 0.00 73.61
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.95% 0.00% 1.36%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.62 9.74
Enterprise Value to Revenue (EV/Rev)		 0.64 0.67 0.89 0.94 2.16 1.93 2.03 1.14 1.24 1.71 1.80
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 74.04 0.00 34.04
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 80.79 0.00 65.48
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 197.37 0.00 37.61
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 87.61 0.00 0.00 108.07 21.66 34.45 0.00 13.78 21.46 12.57
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 34.13 69.46 0.00 63.74 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.53
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -2.79 -1.04 -1.14 -1.40 -1.63 -1.86 -1.98 -2.10 -1.98 -1.03 -0.43
Leverage Ratio		 23.88 2.72 2.40 2.95 3.23 3.20 3.08 3.29 3.18 3.35 3.43
Compound Leverage Factor		 24.76 2.76 2.41 2.96 3.23 3.20 3.08 3.29 3.18 3.35 3.43
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 34.58%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 34.58%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 65.42%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.84
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.88
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.14
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.07
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 3.65 2.51 1.74 2.61 5.47 3.77 4.36 2.44 3.23 1.44 1.99
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.17 1.92 1.52 1.48 1.39 1.48 1.47 1.40 1.47 0.82 0.78
Quick Ratio		 1.09 1.87 1.42 1.42 1.35 1.38 1.37 1.31 1.36 0.73 0.76
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1.03 -1.13 -0.77 -1.17 -0.19 1.53 0.93 -1.00 0.73 -12 -1.12
Operating Cash Flow to CapEx		 -491.30% 317.20% -733.02% -2,067.05% 3,641.94% 0.00% 9,410.73% -942.02% 981.80% 4,965.67% 36,463.14%
Free Cash Flow to Firm to Interest Expense		 -57.04 -64.79 -63.81 -291.41 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -18.38 10.65 -36.40 -151.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -22.12 7.29 -41.37 -158.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 3.96 2.48 2.07 2.49 2.83 2.15 2.00 1.94 1.94 1.40 1.12
Accounts Receivable Turnover		 6.97 4.41 4.59 5.77 6.59 6.08 6.93 6.61 6.61 6.85 6.97
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 332.03 291.24 306.62 387.05 600.68 1,129.55 1,982.85 958.22 638.08 564.13 659.47
Accounts Payable Turnover		 4.53 3.27 3.24 3.71 4.28 7.64 3.29 3.15 3.13 2.95 3.05
Days Sales Outstanding (DSO)		 52.39 82.75 79.58 63.29 55.42 60.07 52.68 55.24 55.20 53.30 52.35
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 80.60 111.75 112.73 98.27 85.22 47.76 110.82 115.98 116.50 123.62 119.56
Cash Conversion Cycle (CCC)		 -28.21 -29.00 -33.15 -34.98 -29.80 12.31 -58.14 -60.74 -61.29 -70.32 -67.21
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.26 -0.04 -1.43 -1.63 -2.32 -4.45 -5.58 -5.72 -6.21 5.59 9.06
Invested Capital Turnover		 -52.88 -162.15 -35.15 -18.32 -14.58 -8.02 -6.33 -5.83 -6.32 -143.79 6.69
Increase / (Decrease) in Invested Capital		 0.68 0.23 -1.39 -0.20 -0.69 -2.13 -1.12 -0.14 -0.50 12 3.47
Enterprise Value (EV)		 20 16 23 26 62 52 64 38 47 76 88
Market Capitalization		 22 22 29 31 68 62 75 48 60 82 93
Book Value per Share		 $0.06 $0.33 $0.18 $0.14 $0.12 $0.19 $0.21 $0.18 $0.25 $0.36 $0.43
Tangible Book Value per Share		 $0.06 $0.32 $0.18 $0.14 $0.12 $0.19 $0.21 $0.18 $0.23 ($0.48) ($0.37)
Total Capital		 1.09 6.04 4.34 3.28 3.03 4.86 5.43 4.88 7.33 12 21
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.36
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -1.35 -6.08 -5.77 -4.91 -5.35 -9.31 -11 -11 -14 -6.10 -4.86
Capital Expenditures (CapEx)		 0.07 0.06 0.06 0.03 0.02 0.00 0.02 0.04 0.34 0.07 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.35 -0.23 -1.66 -1.80 -2.49 -4.54 -5.60 -5.77 -6.75 -9.28 -10
Debt-free Net Working Capital (DFNWC)		 1.00 5.85 4.11 3.11 2.87 4.77 5.41 4.83 6.80 -3.18 1.85
Net Working Capital (NWC)		 1.00 5.85 4.11 3.11 2.87 4.77 5.41 4.83 6.80 -3.18 -5.51
Net Nonoperating Expense (NNE)		 -1.12 -0.40 0.13 0.31 0.08 0.07 0.09 0.49 -0.34 3.25 1.08
Net Nonoperating Obligations (NNO)		 -1.35 -6.08 -5.77 -4.91 -5.35 -9.31 -11 -11 -14 -6.10 -4.86
Total Depreciation and Amortization (D&A)		 0.17 0.09 0.18 0.26 0.15 0.14 0.08 0.02 0.05 0.84 1.25
Debt-free, Cash-free Net Working Capital to Revenue		 -1.11% -0.96% -6.45% -6.43% -8.63% -16.72% -17.63% -17.51% -17.90% -20.79% -21.15%
Debt-free Net Working Capital to Revenue		 3.14% 24.27% 15.97% 11.09% 9.96% 17.55% 17.02% 14.68% 18.03% -7.12% 3.78%
Net Working Capital to Revenue		 3.14% 24.27% 15.97% 11.09% 9.96% 17.55% 17.02% 14.68% 18.03% -7.12% -11.23%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.04 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) ($0.01) $0.00 $0.02 ($0.13) $0.04
Adjusted Weighted Average Basic Shares Outstanding		 17.45M 17.77M 24.17M 24.19M 24.47M 26.21M 26.62M 27.33M 26.86M 28.86M 30.68M
Adjusted Diluted Earnings per Share		 $0.04 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) ($0.01) $0.00 $0.02 ($0.13) $0.04
Adjusted Weighted Average Diluted Shares Outstanding		 17.96M 17.77M 24.17M 24.19M 24.47M 26.21M 26.62M 27.33M 29.14M 28.86M 31.50M
Adjusted Basic & Diluted Earnings per Share		 $0.04 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) ($0.01) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 18.39M 23.91M 23.24M 23.47M 23.82M 24.76M 26.01M 27.33M 29.60M 32.55M 32.83M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.35 -0.90 -2.16 -1.37 -0.88 -0.60 -0.20 -1.14 0.24 -0.54 2.35
Normalized NOPAT Margin		 -1.09% -3.74% -8.39% -4.87% -3.05% -2.20% -0.62% -3.47% 0.63% -1.21% 4.79%
Pre Tax Income Margin		 -1.60% -5.54% -11.93% -6.77% -3.99% -2.84% -0.89% -4.93% 1.53% -8.23% 2.75%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -27.32 -75.84 -255.06 -472.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -19.17 -51.82 -179.93 -341.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -31.06 -79.20 -260.03 -480.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -22.91 -55.18 -184.90 -348.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 6.68% -7.58% -8.69% -9.10% -20.84% -48.56% -62.44% -5.75% 18.24% -14.64% 73.85%

Quarterly Metrics And Ratios for Research Solutions

This table displays calculated financial ratios and metrics derived from Research Solutions' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 29,596,086.00 29,624,085.00 32,620,507.00 32,282,039.00 32,554,568.00 32,513,172.00 32,646,827.00 32,458,727.00 32,828,173.00 - 32,905,476.00
DEI Adjusted Shares Outstanding		 29,596,086.00 29,624,085.00 32,620,507.00 32,282,039.00 32,554,568.00 32,513,172.00 32,646,827.00 32,458,727.00 32,828,173.00 - 32,905,476.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.03 0.00 0.00 -0.09 0.02 -0.06 0.01 0.07 0.02 - 0.03
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 15.85% 18.32% 17.15% 21.83% 19.71% 15.52% 4.50% 2.51% 2.22% -1.02% -4.26%
EBITDA Growth		 -500.44% 145.16% 67.63% -722.96% 214.27% -1,578.73% 26.38% 208.23% 5.78% 152.58% 165.98%
EBIT Growth		 -538.34% 82.90% -49.93% -842.46% 174.61% -4,409.97% 93.35% 184.88% 7.75% 128.28% 391.08%
NOPAT Growth		 -536.50% -27.49% -57.63% 81.48% 178.63% 122.11% 832.17% 159.20% 54.60% 1,019.45% 94.25%
Net Income Growth		 -560.49% 79.01% -67.78% -850.83% 167.71% -3,592.54% 183.71% 183.66% 12.02% 127.62% 297.38%
EPS Growth		 -500.00% 100.00% -100.00% -1,000.00% 150.00% 0.00% 0.00% 188.89% 0.00% 128.57% 200.00%
Operating Cash Flow Growth		 -793.95% -64.07% 137.60% 29.75% 211.59% 212.88% 43.44% 15.18% 31.31% 34.59% -65.16%
Free Cash Flow Firm Growth		 -521.70% -7,342.87% -3,898.62% -1,611.50% -189.24% 122.95% 119.45% 80.00% 49.35% -205.15% -294.64%
Invested Capital Growth		 40.92% 300.64% 272.58% 190.01% 294.80% -34.41% -25.32% 62.03% 87.43% 65.94% 93.55%
Revenue Q/Q Growth		 1.02% 2.51% 17.47% 0.15% -0.73% -1.08% 6.27% -1.76% -1.01% -4.22% 2.79%
EBITDA Q/Q Growth		 -325.90% 112.48% 282.24% -678.19% 141.44% -261.47% 132.67% 395.18% -59.50% -19.74% 65.25%
EBIT Q/Q Growth		 -355.09% 95.45% 372.87% -2,446.86% 125.63% -374.75% 111.70% 930.24% -67.46% -27.88% 103.12%
NOPAT Q/Q Growth		 -401.39% 61.78% 119.14% 723.36% 30.59% -89.26% 706.91% 128.95% -22.11% -22.20% 40.02%
Net Income Q/Q Growth		 -362.96% 94.57% 242.28% -3,797.50% 123.71% -396.00% 110.93% 990.36% -68.25% -27.02% 57.28%
EPS Q/Q Growth		 -500.00% 100.00% 0.00% 0.00% 122.22% -450.00% 114.29% 700.00% -75.00% 0.00% 50.00%
Operating Cash Flow Q/Q Growth		 -149.99% 143.50% 513.56% -2.75% -57.01% 21.97% 181.29% -21.91% -50.99% 25.01% -27.17%
Free Cash Flow Firm Q/Q Growth		 -478.80% -504.02% 9.22% 27.23% 27.51% 147.93% -23.06% -174.82% -83.57% 0.50% -42.42%
Invested Capital Q/Q Growth		 51.81% 476.16% -12.06% -43.53% 4.29% 26.66% 0.13% 22.51% 20.64% 12.13% 16.79%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 40.07% 43.47% 45.25% 46.51% 47.87% 48.86% 49.50% 50.99% 50.56% 52.38% 51.69%
EBITDA Margin		 -8.94% 1.09% 3.54% -20.43% 8.53% -13.92% 4.28% 21.57% 8.83% 7.40% 11.89%
Operating Margin		 -10.92% -4.07% 0.72% 5.45% 5.37% 0.78% 4.40% 9.69% 7.81% 6.27% 8.62%
EBIT Margin		 -9.53% -0.42% 0.98% -23.00% 5.94% -16.49% 1.82% 19.04% 6.26% 4.71% 9.31%
Profit (Net Income) Margin		 -9.82% -0.52% 0.63% -23.25% 5.55% -16.62% 1.71% 18.98% 6.09% 4.64% 7.10%
Tax Burden Percent		 103.07% 123.08% 64.18% 101.11% 93.54% 100.77% 94.17% 99.66% 97.24% 98.41% 97.49%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 78.16%
Effective Tax Rate		 0.00% 0.00% 35.82% 0.00% 6.46% 0.00% 5.83% 0.34% 2.76% 1.59% 2.51%
Return on Invested Capital (ROIC)		 0.00% -41.04% 9.46% 0.00% 164.89% 2.82% 23.34% 64.62% 44.68% 30.90% 37.66%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -44.48% 9.22% 0.00% 164.12% 66.39% 30.99% 43.46% 47.89% 35.05% 41.36%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 31.66% -7.35% 0.00% -140.40% -17.03% -9.84% -18.60% -19.57% -10.76% -11.70%
Return on Equity (ROE)		 -10.34% -9.37% 2.12% -39.81% 24.48% -14.21% 13.50% 46.02% 25.12% 20.14% 25.96%
Cash Return on Invested Capital (CROIC)		 0.00% -156.86% -166.25% -220.72% -139.62% 52.73% 44.83% -15.31% -28.63% -14.81% -27.84%
Operating Return on Assets (OROA)		 -18.65% -0.61% 1.36% -32.22% 8.51% -19.33% 2.06% 21.23% 7.11% 5.33% 9.94%
Return on Assets (ROA)		 -19.22% -0.75% 0.87% -32.58% 7.96% -19.48% 1.94% 21.16% 6.91% 5.24% 7.58%
Return on Common Equity (ROCE)		 -10.34% -9.37% 2.12% -39.81% 24.48% -14.21% 13.50% 46.02% 25.12% 20.14% 25.96%
Return on Equity Simple (ROE_SIMPLE)		 -9.16% -3.07% -4.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.77 -0.29 0.06 0.46 0.60 0.06 0.52 1.20 0.94 0.73 1.02
NOPAT Margin		 -7.65% -2.85% 0.46% 3.82% 5.02% 0.55% 4.14% 9.65% 7.60% 6.17% 8.40%
Net Nonoperating Expense Percent (NNEP)		 -2.16% 3.44% 0.25% -33.44% 0.76% -63.57% -7.65% 21.15% -3.21% -4.15% -3.70%
Return On Investment Capital (ROIC_SIMPLE)		 - -2.11% 0.40% 3.96% 4.74% 0.43% 3.04% 5.64% 4.09% 2.97% 3.86%
Cost of Revenue to Revenue		 59.93% 56.53% 54.75% 53.49% 52.13% 51.14% 50.50% 49.01% 49.44% 47.62% 48.31%
SG&A Expenses to Revenue		 50.40% 46.04% 41.97% 38.49% 39.91% 45.51% 42.63% 38.77% 40.18% 43.43% 40.49%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 50.99% 47.55% 44.52% 41.05% 42.50% 48.08% 45.10% 41.30% 42.75% 46.11% 43.07%
Earnings before Interest and Taxes (EBIT)		 -0.96 -0.04 0.12 -2.79 0.72 -1.97 0.23 2.37 0.77 0.56 1.13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.90 0.11 0.43 -2.48 1.03 -1.66 0.54 2.68 1.09 0.87 1.44
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 10.74 5.52 7.30 7.04 6.97 12.13 7.56 6.69 7.85 5.61 3.90
Price to Tangible Book Value (P/TBV)		 66.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.89 1.89 2.43 1.84 1.91 2.80 1.74 1.90 2.48 1.96 1.53
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 73.61 90.98 24.95 16.46
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.36% 1.10% 4.01% 6.07%
Enterprise Value to Invested Capital (EV/IC)		 0.00 6.60 9.98 13.62 14.05 17.75 10.95 9.74 10.77 7.48 4.86
Enterprise Value to Revenue (EV/Rev)		 1.64 1.83 2.33 1.71 1.76 2.72 1.66 1.80 2.39 1.86 1.43
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 2,476.81 0.00 0.00 0.00 0.00 34.04 44.40 17.68 11.45
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 65.48 83.91 23.36 14.43
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 119.94 125.87 59.13 37.61 43.62 26.82 17.86
Enterprise Value to Operating Cash Flow (EV/OCF)		 25.45 38.44 31.88 21.46 15.91 22.43 12.05 12.57 16.16 11.99 12.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 26.67 20.89 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.36 0.54 0.53 0.47 0.42 0.38
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.66 -0.71 -0.80 -1.03 -0.86 -0.26 -0.32 -0.43 -0.41 -0.31 -0.28
Leverage Ratio		 3.27 2.89 2.99 3.35 3.31 3.28 3.39 3.43 3.06 3.07 3.01
Compound Leverage Factor		 3.27 2.89 2.99 3.35 3.31 3.28 3.39 3.43 3.06 3.07 2.35
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 26.27% 34.89% 34.58% 31.87% 29.75% 27.72%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 26.27% 34.89% 34.58% 31.87% 29.75% 27.72%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 73.73% 65.11% 65.42% 68.13% 70.25% 72.28%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -1.48 -2.34 2.84 2.75 1.41 1.20
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 1.39 1.49 -1.88 -1.76 -0.96 -0.78
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 3.80 4.39 3.14 2.70 2.13 1.88
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -3.59 -2.80 -2.07 -1.73 -1.45 -1.22
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 2.92 1.85 2.42 1.51 2.13 2.49 1.58 2.07 2.71 2.41 1.99
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.19 0.70 0.74 0.82 0.89 0.77 0.76 0.78 0.79 0.79 0.82
Quick Ratio		 1.09 0.60 0.65 0.73 0.81 0.71 0.70 0.76 0.76 0.76 0.78
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -2.84 -17 -16 -11 -8.22 3.94 3.03 -2.27 -4.17 -4.14 -5.90
Operating Cash Flow to CapEx		 -2,233.77% 1,498.24% 100,934.88% 14,264.04% 0.00% 19,029.87% 46,907.05% 29,374.71% 6,312.33% 19,710.30% 24,900.52%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -23.94
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.09
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.07
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.96 1.43 1.38 1.40 1.43 1.17 1.13 1.12 1.14 1.13 1.07
Accounts Receivable Turnover		 6.72 6.49 6.01 6.85 7.31 6.69 6.53 6.97 7.47 7.70 6.40
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 569.78 513.73 574.26 564.13 571.92 578.90 632.63 659.47 702.88 765.28 825.45
Accounts Payable Turnover		 3.36 3.34 2.94 2.95 3.00 3.01 2.88 3.05 3.11 3.34 3.11
Days Sales Outstanding (DSO)		 54.31 56.23 60.71 53.30 49.96 54.53 55.88 52.35 48.83 47.39 57.02
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 108.66 109.23 124.29 123.62 121.50 121.45 126.75 119.56 117.31 109.39 117.40
Cash Conversion Cycle (CCC)		 -54.35 -53.00 -63.59 -70.32 -71.54 -66.91 -70.87 -67.21 -68.48 -62.00 -60.38
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -2.99 11 9.91 5.59 5.83 7.39 7.40 9.06 11 12 14
Invested Capital Turnover		 -9.69 14.40 20.38 -143.79 32.83 5.17 5.63 6.69 5.88 5.01 4.48
Increase / (Decrease) in Invested Capital		 2.07 17 16 12 8.83 -3.88 -2.51 3.47 5.10 4.87 6.92
Enterprise Value (EV)		 64 74 99 76 82 131 81 88 118 92 70
Market Capitalization		 74 77 103 82 89 135 85 93 122 97 74
Book Value per Share		 $0.23 $0.47 $0.43 $0.36 $0.39 $0.34 $0.34 $0.43 $0.48 $0.52 $0.58
Tangible Book Value per Share		 $0.04 ($0.47) ($0.41) ($0.48) ($0.43) ($0.48) ($0.46) ($0.37) ($0.31) ($0.25) ($0.19)
Total Capital		 6.89 14 14 12 13 15 17 21 23 25 26
Total Debt		 0.00 0.00 0.00 0.00 0.00 3.96 6.02 7.36 7.30 7.30 7.31
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -9.88 -2.70 -4.22 -6.10 -6.92 -3.74 -3.83 -4.86 -4.66 -4.97 -4.74
Capital Expenditures (CapEx)		 0.03 0.02 0.00 0.01 0.00 0.01 0.01 0.01 0.02 0.01 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -6.99 -7.79 -8.92 -9.28 -8.78 -8.51 -9.90 -10 -9.88 -9.90 -9.17
Debt-free Net Working Capital (DFNWC)		 2.89 -5.09 -4.70 -3.18 -1.86 -0.81 -0.05 1.85 2.07 2.36 2.88
Net Working Capital (NWC)		 2.89 -5.09 -4.70 -3.18 -1.86 -4.77 -6.07 -5.51 -5.22 -4.94 -4.43
Net Nonoperating Expense (NNE)		 0.22 -0.24 -0.02 3.28 -0.06 2.05 0.31 -1.16 0.19 0.18 0.16
Net Nonoperating Obligations (NNO)		 -9.88 -2.70 -4.22 -6.10 -6.92 -3.74 -3.83 -4.86 -4.66 -4.97 -4.74
Total Depreciation and Amortization (D&A)		 0.06 0.16 0.31 0.31 0.31 0.31 0.31 0.32 0.32 0.32 0.31
Debt-free, Cash-free Net Working Capital to Revenue		 -17.88% -19.15% -21.01% -20.79% -18.85% -17.65% -20.31% -21.15% -20.04% -20.13% -18.83%
Debt-free Net Working Capital to Revenue		 7.41% -12.51% -11.07% -7.12% -3.99% -1.68% -0.10% 3.78% 4.20% 4.80% 5.93%
Net Working Capital to Revenue		 7.41% -12.51% -11.07% -7.12% -3.99% -9.90% -12.45% -11.23% -10.59% -10.03% -9.10%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.04) $0.00 $0.00 ($0.09) $0.02 ($0.07) $0.01 $0.08 $0.02 $0.02 $0.03
Adjusted Weighted Average Basic Shares Outstanding		 27.05M 28.09M 30.02M 28.86M 30.35M 30.42M 31.03M 30.68M 31.23M 31.63M 32.00M
Adjusted Diluted Earnings per Share		 ($0.04) $0.00 $0.00 ($0.09) $0.02 ($0.07) $0.01 $0.08 $0.02 $0.02 $0.03
Adjusted Weighted Average Diluted Shares Outstanding		 27.05M 28.09M 33.51M 28.86M 33.23M 30.42M 32.14M 31.50M 32.07M 32.33M 32.44M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 29.62M 32.62M 32.28M 32.55M 32.51M 32.65M 32.46M 32.83M 32.87M 32.91M 33.45M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.77 -0.29 0.06 0.46 0.60 0.06 0.52 1.20 0.94 0.73 1.02
Normalized NOPAT Margin		 -7.65% -2.85% 0.46% 3.82% 5.02% 0.55% 4.14% 9.65% 7.60% 6.17% 8.40%
Pre Tax Income Margin		 -9.53% -0.42% 0.98% -23.00% 5.94% -16.49% 1.82% 19.04% 6.26% 4.71% 7.28%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.58
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.13
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.56
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.12
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -20.97% -28.96% -93.57% -14.64% -24.61% -17.03% -24.02% 73.85% 69.98% 19.85% 1.63%

Financials Breakdown Chart

Key Financial Trends

Research Solutions (NASDAQ: RSSS) posted another profitable quarter in Q3 2026, but the headline results still show a business that is growing modestly while carrying a heavy balance sheet burden. Revenue rose slightly year over year, earnings remained positive, and operating cash flow improved versus prior quarters. However, leverage remains high, working-capital swings are meaningful, and financing cash outflows continue to weigh on the company’s overall cash position.

  • Profitability held up in Q3 2026. The company generated $860,206 in net income on $12.1 million of revenue, showing it is still operating in the black.
  • Operating cash flow was solid. RSSS produced $1.0 million in cash from operations in Q3 2026, which is a healthy result relative to quarterly earnings.
  • Gross profit remained strong. Gross profit of $6.3 million translated to a gross margin of about 51.7%, indicating the core business still has decent pricing power.
  • Revenue has been fairly stable year over year. Q3 2026 revenue of $12.1 million was slightly above the $12.2 million posted in Q1 2026 and modestly above Q3 2025 levels, suggesting the top line is not deteriorating materially.
  • Cash and equivalents remain sizable. The balance sheet showed $12.1 million in cash at the end of Q3 2026, giving the company some liquidity cushion.
  • Depreciation and non-cash items remain consistent. Depreciation hovered around $312,000 to $316,000 per quarter, and non-cash adjustments continue to support operating cash flow.
  • Quarterly earnings per share stayed low but positive. Diluted EPS was $0.03 in Q3 2026, reflecting profitability, but not at a level that would yet suggest strong earnings leverage.
  • Operating income was thin relative to revenue. Q3 2026 operating income was just $1.0 million, equal to an operating margin of about 8.6%, which leaves little room if costs rise.
  • Debt remains a major overhang. Short-term debt totaled $7.3 million at quarter-end, against $12.1 million in cash and $45.9 million in total assets, meaning the capital structure is still leveraged.
  • Financing outflows pressured cash. Q3 2026 financing activities used $1.2 million, driven largely by other financing items, and net cash fell by $212,384 during the quarter.

Trend-wise, RSSS has improved dramatically from the weak periods in 2024, when the company posted large losses and negative operating cash flow in some quarters. Since then, revenue has stabilized around the $12 million range per quarter, gross margins have held up, and the company has returned to consistent profitability. That said, the improvement has not yet translated into a cleaner balance sheet or consistently strong free cash generation after financing items.

Bottom line: Research Solutions looks operationally healthier than it did a year ago, but investors should still watch debt levels, financing cash outflows, and whether earnings can keep growing without a large increase in operating costs or working-capital needs.

07/21/26 07:27 AM ETAI Generated. May Contain Errors.

Research Solutions Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Research Solutions' fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

In the past 10 years, Research Solutions' net income has ranged from -$3.79 million in 2024 to $1.27 million in 2025, and is currently $1.27 million as of their latest financial filing in 2025. Check out Research Solutions' forecast to explore projected trends and price targets.

Research Solutions' total operating income in 2025 was $2.50 million, based on the following breakdown:
  • Total Gross Profit: $24.20 million
  • Total Operating Expenses: $21.69 million

Over the last 10 years, Research Solutions' total revenue changed from $31.90 million in 2015 to $49.06 million in 2025, a change of 53.8%.

Research Solutions' total liabilities were at $32.19 million at the end of 2025, a 6.7% increase from 2024, and a 440.2% increase since 2015.

In the past 10 years, Research Solutions' cash and equivalents has ranged from $1.35 million in 2015 to $13.55 million in 2023, and is currently $12.23 million as of their latest financial filing in 2025.

Over the last 10 years, Research Solutions' book value per share changed from 0.06 in 2015 to 0.43 in 2025, a change of 609.3%.


Related Companies

Financial statements for NASDAQ:RSSS last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel